Association between baseline VEGF/sVEGFR-2 and VEGF/TSP-1 ratios and response to metronomic chemotherapy using cyclophosphamide and celecoxib in patients with advanced breast cancer

Background: Metronomic chemotherapy (MCT) with cyclophosphamide (Cy) and celecoxib (Cel) has therapeutic efficacy and low toxicity profile in advanced breast cancer patients (ABCP), but no reliable biomarkers of response have been found yet that allow patient selection for treatment. AIM: To investi...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Perroud, Herman A, Rico, María José, Alasino, Carlos María, Pezzotto, Stella Maris, Rozados, Viviana R., Scharovsky, O. Graciela
Formato: article artículo publishedVersion
Lenguaje:Inglés
Publicado: Indian Cancer Society and Indian Society of Oncology 2018
Materias:
Biomarkers
Celecoxib 
Cyclophosphamide
metronomic chemotherapy
Acceso en línea:http://hdl.handle.net/2133/11554
http://hdl.handle.net/2133/11554
Aporte de:
Repositorio Hipermedial de la Universidad Nacional de Rosario (UNR) de Universidad Nacional de Rosario

Ejemplares similares

Ejemplares similares